Renal Safety of Hydroxyethyl starch 130/0.42 After Cardiac Surgery: A Retrospective Cohort Analysis

被引:3
|
作者
Morath, Benedict [1 ,2 ,3 ]
Meid, Andreas D. [1 ]
Rickmann, Johannes [4 ]
Soethoff, Jasmin [5 ]
Verch, Markus [5 ]
Karck, Matthias [5 ]
Zaradzki, Marcin [5 ]
机构
[1] Heidelberg Univ Hosp, Dept Clin Pharmacol & Pharmacoepidemiol, Heidelberg, Germany
[2] Heidelberg Univ, Cooperat Unit Clin Pharm, Heidelberg, Germany
[3] Heidelberg Univ Hosp, Hosp Pharm, Heidelberg, Germany
[4] Heidelberg Univ Hosp, Ctr Informat & Med Technol, Heidelberg, Germany
[5] Univ Hosp Heidelberg, Dept Cardiac Surg, Heidelberg, Germany
关键词
ACUTE KIDNEY INJURY; INFLAMMATORY RESPONSE SYNDROME; FLUID RESUSCITATION; SURGICAL-PATIENTS; SALINE; PATHOPHYSIOLOGY; CRYSTALLOIDS; MANAGEMENT; MORTALITY; COLLOIDS;
D O I
10.1007/s40264-021-01116-5
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction The risk for renal complications from hydroxyethyl starch 130/0.42 (HES) impacts treatment decisions in patients after cardiac surgery. Objective The objective of this study was to determine the impact of postoperatively administered HES on renal function and 90-day mortality compared to sole crystalloid administration in patients after elective cardiac surgery. Methods Using electronic health records from a university hospital, confounding-adjusted models analyzed the associations between postoperative HES administration and the occurrence of postoperative acute kidney injury. In addition, 90-day mortality was evaluated. The impact of HES dosage and timing on renal function on trajectories of estimated glomerular filtration rates over the postoperative period was investigated using linear mixed-effects models. Results Overall 1009 patients (45.0%) experienced acute kidney injury. Less acute kidney injury occurred in patients receiving HES compared with patients receiving only crystalloids for fluid resuscitation (43.7% vs 51.2%, p = 0.008). In multivariate acute kidney injury models, HES had a protective association (odds ratio: 0.89; 95% confidence interval 0.82-0.96). Crystalloids were not as protective as HES (odds ratio: 0.98; 95% confidence interval 0.95-1.00). There was no association between HES and 90-day mortality (odds ratio: 1.05; 95% confidence interval 0.88-1.25). Renal function trajectories were dose dependent and biphasic, HES appeared to slow down the late postoperative decline. Conclusions This study showed no association between HES and the postoperative occurrence of acute kidney injury and thus further closes the evidence gap on HES safety in cardiac surgery patients. Although this was a retrospective cohort study, the results indicated that HES might be safely administered to cardiac surgery patients with regard to renal outcomes, especially if it was administered early and dosed appropriately.
引用
收藏
页码:1311 / 1321
页数:11
相关论文
共 50 条
  • [21] Attenuation of capillary leakage by hydroxyethyl starch (130/0.42) in a porcine model of septic shock
    Marx, Gernot
    Pedder, Samantha
    Smith, Linda
    Swaraj, Seshapillai
    Grime, Steve
    Stockdale, Harold
    Leuwer, Martin
    CRITICAL CARE MEDICINE, 2006, 34 (12) : 3005 - 3010
  • [22] Compatibility of common IV drugs with 6% hydroxyethyl starch 130/0.42 and 4% gelatin
    Heiderich, Sebastian
    der Springe, Anna Auf
    Juergens, Jonas
    Koppert, Wolfgang
    Leffler, Andreas
    Suempelmann, Robert
    Dennhardt, Nils
    PEDIATRIC ANESTHESIA, 2018, 28 (02) : 87 - 93
  • [23] Modern hydroxyethyl starch and acute kidney injury after cardiac surgery: a prospective multicentre cohort
    Vives, M.
    Callejas, R.
    Duque, P.
    Echarri, G.
    Wijeysundera, D. N.
    Hernandez, A.
    Sabate, A.
    Bes-Rastrollo, M.
    Monedero, P.
    BRITISH JOURNAL OF ANAESTHESIA, 2016, 117 (04) : 458 - 463
  • [24] Erroneous conclusions about the safety of hydroxyethyl starch 130/0.4 in paediatric cardiac patients?
    Wilson, J.
    ANAESTHESIA, 2018, 73 (05) : 649 - 650
  • [25] The effects of hydroxyethyl starch 130/0.4 on perioperative renal function in patients undergoing cardiac surgery: A randomised controlled trial
    Nagaya, Kei
    Yoshida, Akiko
    Ito, Yosuke
    Watanabe, Suguru
    Minagawa, Tadanori
    Saijo, Yoshifumi
    ANNALS OF MEDICINE AND SURGERY, 2022, 81
  • [26] The effects of hydroxyethyl starch 130/0.4 on perioperative renal function in patients undergoing cardiac surgery: A randomised controlled trial
    Nagaya, Kei
    Yoshida, Akiko
    Ito, Yosuke
    Watanabe, Suguru
    Minagawa, Tadanori
    Saijo, Yoshifumi
    ANNALS OF MEDICINE AND SURGERY, 2022, 81
  • [27] Hydroxyethyl starch-induced bleeding after cardiac surgery
    Haynes, Gary R.
    CRITICAL CARE MEDICINE, 2011, 39 (05) : 1239 - 1240
  • [28] Renal impairment in cardiac surgery patients receiving hydroxyethyl starch - Reply
    Boldt, J
    INTENSIVE CARE MEDICINE, 2004, 30 (03) : 521 - 521
  • [29] The Use of Hydroxyethyl Starch 130/0.4 in Surgery Patients
    Reinhart, Konrad
    ANESTHESIA AND ANALGESIA, 2018, 127 (02): : E27 - E27
  • [30] Using of 6% hydroxyethyl starch 130/0.42 in term neonates during acute period of hie
    Surkov, D.
    PEDIATRIC ANESTHESIA AND CRITICAL CARE JOURNAL, 2019, 7 (01): : 1 - 7